Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study

INIS

• drugs 100%
• inhibition 100%
• precision 100%
• peptides 66%
• ligands 66%
• molecular dynamics method 66%
• comparative evaluations 33%
• malignancies 33%
• tools 33%
• interactions 33%
• heart disease 33%
• nervous system diseases 33%
• screening 33%
• kidneys 33%
• binding energy 33%
• simulation 33%
• pathology 33%
• obesity 33%
• angiotensin 33%
• filters 33%
• endothelins 33%

Chemistry

• Peptide Hydrolase Inhibitor 100%
• Physiological Role 33%
• Beta-Amyloid 33%
• Natriuretic Peptide 33%